Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
OTCInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.09 → 0.09 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for MAPS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA improves to $5M-$7M range | It targets adjusted EBITDA between $5M and $7M. | Improving | Adjusted EBITDA falls below $5M in any quarter after 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround thesis, not a proven growth compounder. Its current state is watch: recent performance remains below its industry cohort, and confidence in the assessment has fallen from high to medium.
MAPS is described as cheap versus peers, but the expectations gap is slightly negative, which suggests the valuation signal is not clearly supportive. The evidence labels pricing as justified and fragility as low, but does not provide enough detail to say what specific operating expectations the market assumes.
Near term, revenue and average monthly paying clients have declined, while adjusted EBITDA has also fallen despite management's stated focus on growth and cost discipline. Cash was $60.5 million in 2026-Q2, but regulatory compliance remains a risk after the company voluntarily delisted from Nasdaq and deregistered under the Exchange Act. The available evidence does not establish a clear improvement in the multi-year operating trend.
The thesis depends on management stabilizing revenue and clients, improving adjusted EBITDA, and addressing compliance matters. A guidance cut would be a meaningful negative; Fed rate cuts or steadier results and guidance from large technology companies could support the sector backdrop. The October M&A disclosures include both an agreement and a termination, and the evidence does not show their business impact.
Over the next 1 to 3 years, MAPS remains a high-risk turnaround case with limited proof that its key operating measures have stabilized. The long-term thesis hinges on execution and compliance, while the available evidence leaves the direction of improvement uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Management plans to fix Nasdaq listing problems. |
| Intact |
| Failure to resolve delisting within 4 quarters |
Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue stabilizes near $43.6M in 2026-Q1 | A primary condition in WM Technology, Inc.'s published investment case. The stated target is >= $43.6M. | Broken | Revenue falls below $43.6M in any quarter after 2026-Q1 | Revenue: $42.446M FY2026-Q2; GAAP. Published target: >= $43.6M. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 6, 202642,446,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Second Quarter 2026 Financial Highlights • Revenues for the second quarter ended June 30, 2026 were $42.4 million as compared to $44.8 million in the prior year period.” “First Quarter 2026 Financial Highlights • Revenues for the first quarter ended March 31, 2026 were $43.6 million as compared to $44.6 million in the prior year period.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.08 → $0.09 · observed estimates
$0.16B → $0.16B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-07-25 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-07-26 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-07-27 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-07-28 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-07-29 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-07-30 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-07-31 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-01 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-02 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-03 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-04 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-05 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-06 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-07 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-08 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-09 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-10 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-12 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-13 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-14 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-15 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-16 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-17 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-18 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-19 | $0.08 | $155,300,000 | 1 / 1 |
| 2026-08-20 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-21 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-22 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-23 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-24 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-25 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-26 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-27 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-28 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-29 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-30 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-08-31 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-01 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-02 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-03 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-04 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-05 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-06 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-07 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-08 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-09 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-10 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-11 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-12 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-13 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-14 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-15 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-16 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-17 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-18 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-19 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-20 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-21 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-22 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-23 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-24 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-25 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-26 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-27 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-28 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-29 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-09-30 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-01 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-02 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-03 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-04 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-05 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-06 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-07 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-08 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-09 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-10 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-11 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-12 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-13 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-14 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-15 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-16 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-17 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-18 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-19 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-20 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-21 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-22 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-23 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-24 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-25 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-26 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-27 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-28 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-29 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-30 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-10-31 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-11-01 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-11-02 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-11-03 | $0.09 | $162,700,000 | 1 / 1 |
| 2026-11-04 | $0.09 | $162,700,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.